New evidence of a causal link between herpes viruses and Alzheimer’s reinvigorates research into the possible role of infections — and their treatment — in the disease
What causes Alzheimer’s disease? The answer could be right under our noses, says leading expert Professor Ruth Itzhaki. Her latest paper presents a lifetime of research evidence that the herpes virus responsible for cold sores can also cause Alzheimer’s – and new data which show antiviral drugs drastically reduce risk of senile dementia in patients with severe herpes infections. The review in Frontiers in Ageing Neuroscience raises the tantalizing prospect of a simple, effective preventive treatment for one of humanity’s costliest disorders.
The HSV1 theory of Alzheimer’s disease
Herpes viruses are the dreaded ‘gift that keeps on giving’. They remain lifelong in our neurons and immune cells, reactivating and resurfacing in characteristic blisters when we’re run down by stress or illness. Most people are infected by Herpes Simplex Virus 1 (HSV1) by the time they reach old age.
But what happens to infected neurons in our brain during this reactivation?
“HSV1 could account for 50% or more of Alzheimer’s disease cases,” says Professor Itzhaki, who has spent over 25 years at the University of Manchester investigating a potential link.
HSV1 is better known as the cause of cold sores. Itzhaki has shown previously that cold sores occur more frequently in carriers of APOE-?4 – a gene variant that confers increased risk of Alzheimer’s.
“Our theory is that in APOE-?4 carriers, reactivation is more frequent or more harmful in HSV1-infected brain cells, which as a result accumulate damage that culminates in development of Alzheimer’s.”
Proving the theory
Few countries collect the population data required to test this theory – for example, to find out whether antiviral treatments reduce dementia risk.
In Taiwan however, researchers have done just that. There, 99.9% of the population is enrolled in a National Health Insurance Research Database, which is being extensively mined for information on microbial infections and disease. In 2017-2018 three studies were published describing Taiwanese data on the development of senile dementia – of which Alzheimer’s is the main cause – and the treatment of patients with marked overt signs of infection with HSV or varicella zoster virus (VZV, the chickenpox virus).
“The striking results include evidence that the risk of senile dementia is much greater in those who are infected with HSV, and that anti-herpes antiviral treatment causes a dramatic decrease in number of those subjects severely affected by HSV1 who later develop dementia.”
Previous findings from Itzhaki’s own research group provide a mechanistic link which supports these epidemiological findings. They found that HSV1 causes protein deposits characteristic of Alzheimer’s: ‘plaques’ between neurons, and ‘tangles’ inside of them.
“Viral DNA is located very specifically within plaques in postmortem brain tissue from Alzheimer’s sufferers. The main proteins of both plaques and tangles accumulate also in HSV1-infected cell cultures – and antiviral drugs can prevent this.”
Towards a cure
“It should be stressed that the results of these Taiwanese studies apply only to severe HSV1 (or VZV) infections, which are rare,” admits Itzhaki. “Ideally, we would study dementia rates amongst people who have suffered mild HSV1 infection, including herpes labialis (cold sores) or mild genital herpes, but these are far less likely to be documented.”
Although further work is needed to confirm and define a causal link between HSV1 infection and Alzheimer’s, Itzhaki is enthusiastic about the treatment prospects.
“Considering that over 150 publications strongly support an HSV1 role in Alzheimer’s, these Taiwan findings greatly justify usage of antiherpes antivirals – which are safe and well-tolerated – to treat Alzheimer’s disease.
“They also incentivize development of an HSV1 vaccine, which would likely be the most effective treatment.”
This echoes the growing use worldwide of human papillomavirus (HPV) vaccination to prevent cervical cancer – another virus-disease link which emerged in a similar process of research.
Learn more: Does herpes cause Alzheimer’s?
The Latest on: HSV1 vaccine
[google_news title=”” keyword=”HSV1 vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: HSV1 vaccine
- The structure of HSV-1 gB bound to a potent neutralizing antibody reveals a conservative antigenic domain across herpesviruseson February 26, 2024 at 6:33 am
However, the lack of structural information on neutralizing epitopes for HSV has hindered the design of antibody drugs and vaccine targets. The research team successfully purified the HSV-1 gB/D48 ...
- Structure of HSV-1 gB bound to a potent neutralizing antibody reveals a conservative antigenic domain across herpesviruson February 25, 2024 at 3:59 pm
However, the lack of structural information on neutralizing epitopes for HSV has hindered the design of antibody drugs and vaccine targets. The research team successfully purified the HSV-1 gB/D48 Fab ...
- Novavax and Gavi Settle Dispute Over Covid Vaccines Pact, Avoiding Arbitrationon February 22, 2024 at 5:58 am
Novavax isn’t in a good financial position to be refunding money to customers, having gone through a cost-saving restructuring amid flagging sales of the Covid-19 vaccine that is its only ...
- Proof that nixing vax dissent backfiredon February 21, 2024 at 2:52 am
President Biden receives a fourth dose of the Pfizer/BioNTech COVID-19 vaccine in the South Court Auditorium on March 30, 2022, in Washington, DC. Getty Images As a primary care physician ...
- COVID vaccines linked to slight increases in heart, brain, blood disorders: studyon February 20, 2024 at 5:21 am
COVID vaccines from companies like Pfizer, Moderna and AstraZeneca have been linked to rare occurrences of heart, brain and blood disorders, according to the largest vaccine study to date.
- Largest-ever COVID vaccine study links shot to small increase in heart and brain conditionson February 19, 2024 at 12:35 pm
The largest COVID vaccine study to date has identified some risks associated with the shot. Researchers from the Global Vaccine Data Network (GVDN) in New Zealand analyzed 99 million people who ...
- Are You a Grandparent? These Vaccines Are Importanton February 18, 2024 at 4:00 pm
If you’re the grandparent of children under the age of 5, you may want to chat with your healthcare professional about the shingles, Tdap, MMR, flu, and pneumonia vaccines before getting too close.
- Dementia risk doubled by common herpes virus, study findson February 15, 2024 at 6:12 pm
Infection with the virus that’s the main cause of cold sores may double a person’s risk of developing dementia, according to a new study. Adding to growing evidence of a link between the two, further ...
- The Importance of Tetanus Vaccineon February 11, 2024 at 3:59 pm
What Is the Tetanus Vaccine? The tetanus vaccine is part of the recommended series of childhood and adult immunizations. It protects against the bacterial infection tetanus, also known as lockjaw.
via Bing News